-
Botensilimab, an Fc-enhanced Anti-CTLA-4 Antibody, is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy
Study
phs003704
-
Fgl2 Regulates FcγRIIB+ CD8+ T Cell Responses during Infection
Study
phs003870
-
Anti-TIGIT antibody tiragolumab improves PD-L1 blockade via myeloid and Treg cells
Study
EGAS50000000251
-
Data Access Committee KCL FC
Dac
EGAC00001000386
-
MCF10A 12h IL6 classical signaling
Dataset
EGAD00010001970
-
MCF10A 24h IL6 classical signaling
Dataset
EGAD00010001963
-
Characterization of a human iPSC-derived endocrine pancreas model
Study
EGAS00001001803
-
Expression profiling of a human endocrine pancreas iPSC model
Dataset
EGAD00001002148
-
Ribo-depleted RNA-sequencing of II.3, III.1, and III.3
Dataset
EGAD50000002364
-
Whole exome sequencing of endometriod ovarian cancer tumours
Dataset
EGAD00001006389
-
A Dose Escalation Study of Efmarodocokin Alfa (UTTR1147A) in Healthy Volunteers and Patients with Ulcerative Colitis
Study
EGAS00001006172
-
Characterizing the cell-free transcriptome in a humanized DLBCL patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting
Study
EGAS50000000566
-
High titers and low fucosylation of early phase anti-SARS-CoV-2 IgG promote hyper-inflammation by alveolar macrophages
Study
EGAS00001005206
-
Phenotype information
Dataset
EGAD50000000806
-
RNAseq SCLC Cell lines MYC
Dataset
EGAD00001003099
-
Institut National pour la Recherche Biomedicale Comite d'Access aux Donnees
Dac
EGAC00001001539
-
AREP(Association pour la Recherche et l’Enseignement en Pathologie) Data Access Commitee
Dac
EGAC00001001196
-
Data Access Committee of the MyPAC clinical research group (Sorbonne Universités, UPMC Univ Paris 06, GRC n°07, Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MyPAC)
Dac
EGAC00001000480
-
WES in muscle-invasive bladder cancer (MIBC) treated with durvalumab plus olaparib in the neoadjuvant setting: NEODURVARIB trial
Study
EGAS50000000791
-
Neoadjuvant combination PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable urothelial carcinoma
Study
EGAS00001004074
-
GEDI: A Developmental Model of Gene-Environment Interplay in SUDs: Combined Genotype Dataset from the "Great Smoky Mountains Study" and the "Caring for Children in the Community Study".
Study
phs000852
-
Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial
Study
EGAS50000000470
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
MicroRNAs, Hypertension and End Organ Damage in Humans
Study
phs002389
-
IMCISION DNAseq
Dataset
EGAD00001008139
-
Pediatric Whole Genome Sequencing Diagnostic Utility
Study
EGAS00001001623
-
Sporadic ALS Australia Systems Genomics Consortium (SALSA-SGC)
Study
phs002068
-
RNA-seq of high grade serous ovarian tumours
Dataset
EGAD00001009048
-
RNA-seq of high grade serous ovarian tumours
Dataset
EGAD00001010139
-
Whole Genome Sequencing of a Triple Negative Breast Cancer Patient: Matched Primary Tumor, Normal, Metastasis and Xenograft samples
Study
phs000245
-
DAC Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Dac
EGAC50000000694
-
dataset1
Dataset
EGAD00010002041
-
Plasma whole genome sequencing from patients with stage IV colorectal cancer and microsatellite instability
Dataset
EGAD00001008999
-
Platinum Genomes
Study
phs001224
-
Trisomy21: Risk Factors for Chromosome Nondisjunction (T21NDJ)
Study
phs000718
-
Tissue Site
Dataset
EGAD50000000931
-
Effects of Metformin on Transcriptomic and Metabolomic Profiles in Breast Cancer Survivors Enrolled in the Randomized Placebo-Controlled MetBreCS Trial
Dataset
EGAD50000001274
-
Single Cell Genomic Analysis of Lymphoma
Study
phs002188
-
Oncogenic Ectodomain deletion of FGFR1 caused by Breakage-Fusion-Bridges in Squamous Cell lung Cancer
Study
EGAS00001005059
-
Neoadjuvant immune checkpoint blockade in mismatch-repair proficient colon cancers
Study
EGAS50000000856
-
DAC-2020-03-26-Lemola (DAC-039))
Dataset
EGAD50000000897
-
T cell transcriptional gradient
Dataset
EGAD00001009677
-
DAC for Central African ancient demography processes NGS dataset
Dac
EGAC50000000447
-
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: CheckMate 649 biomarker analyses
Study
EGAS50000000747
-
WGS of Multiple Myeloma/MGUS/SMM cases (germline) - VCF files (SNPs)
Dataset
EGAD50000001800
-
ATAC-seq
Dataset
EGAD00001005967
-
MutWP1: CRUK Grand Challenge Mutographs of Cancer: kidney (2019-03-26)
Dataset
EGAD00001004867
-
scRNA-seq analysis of HGSC tumors, including immune TME, before and after NACT
Dataset
EGAD50000000862
-
Genome-wide evaluation of the maturation of the immune response to the tuberculin skin test from day 2 to day 7
Study
EGAS50000000822
-
CALGB 80303:Genome-Wide Association Study of Advanced Pancreatic Cancer Patients - A Randomized Phase III trial of Gemcitabine Plus Bevacizumab versus Gemcitabine Plus Placebo in Patients with Advanced Pancreatic Cancer
Study
phs000250
-
Evaluation of the ERa binding region activity in breast and endometrial cancer
Study
EGAS50000000009
-
DLBCL gene expression
Dataset
EGAD00010001976
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
H3Africa H3AChipDesign TrypanoGEN1
Dataset
EGAD00001004393
-
Refractory Classic Hodgkins Lymphoma (cHL) sWGS
Dataset
EGAD50000001163
-
RNA-seq of tumor samples from clear cell renal cell carcinoma patients included in the Translational Program of the NIVOREN GETUG-AFU-26 trial.
Dac
EGAC50000000627
-
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial
Study
EGAS50000000387
-
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer
Study
EGAS50000000607
-
dataset1
Dataset
EGAD00001008576
-
Glial Cell Line-Derived Neurotrophic Factor (GDNF) Polymorphisms and Anxiety, Depression
Study
phs000713
-
BLUEPRINT release August 2015, ChIP-Seq for CD8-positive, alpha-beta T cell, on genome GRCh38
Dataset
EGAD00001001513
-
PAX5 biallelic genomic alterations define a novel subgroup of B cell precursor acute lymphoblastic leukemia
Study
EGAS00001003209
-
Sequencing files for "Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy"
Dataset
EGAD00001003200
-
Exome and transcriptome sequencing of Desmoplastic Small Round Cell Sarcoma
Study
EGAS00001004575
-
DAC for EGA study: "ctDNA residual disease analyses during perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma"
Dac
EGAC50000000706
-
Germline Pan-cancer Lynch syndrome sequencing dataset from India
Dataset
EGAD50000002088
-
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
Study
phs003922
-
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
Dataset
EGAD00001007650
-
RNA sequencing of pretreatment, on-treatment and posttreatment gastric and gastroesophageal junction tumors treated with neoadjuvant anti-PD-L1 plus chemotherapy
Dataset
EGAD50000000241
-
The dataset for "ctDNA residual disease analyses during perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma”
Dataset
EGAD50000001701
-
Mult-omics Palbociclib Resistance Study in HR+/HER2– Metastatic Breast Cancer
Dataset
EGAD00001008314
-
BAM files of mapped reads from scDNAsequencing
Study
EGAS50000000019
-
Long-read data (PacBio)
Dataset
EGAD00001006597
-
Drug Perturbation of Primary Lymphoma Patient Samples and RNA Sequencing
Study
EGAS50000001500
-
DKTK Berlin partner site data access committee
Dac
EGAC00001000573
-
Whole Exome Sequencing of a Melanoma Patient with Acquired Resistance to MEK plus CDK4/6 Inhibition
Dataset
EGAD00001003989
-
Lymphoma_primary_patient_drug_perturbed_RNASeq_samples
Dac
EGAC50000000578
-
Sequencing data for Clinical Trial
Study
EGAS50000001144
-
scMultiome (snRNA + snATAC) data of 26 regionally sampled GBM tissue from 6 patients
Dataset
EGAD50000001838
-
Exome-sequencing of human B cell lymphoma cell lines
Dataset
EGAD00001002262
-
IMCISION DNAseq
Study
EGAS00001005466
-
POT1 splice site mutant analysis
Dataset
EGAD00001000786
-
InsPIRE islets
Study
EGAS00001003997
-
Whole Exome Sequencing of gliomas
Dataset
EGAD00001001614
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Dataset
EGAD00001007565
-
463 newly diagnosed patients with Multiple Myeloma underwent whole exome sequencing of tumour and peripheral blood DNA.
Study
EGAS00001001147
-
WGS Fastq files from the CPC-Gene project in support of PRAD-CA, DCC Release 26
Dataset
EGAD00001003706
-
Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multi-Regional Tumor Sequencing
Study
phs001925
-
Whole genomes sequencing BAM files (blood and lung brushings) of COPD cases and controls (EvA)
Dataset
EGAD00001004535
-
Bladder cancer sequencing data
Dataset
EGAD00001001036
-
Low-pass nanopore whole genome sequencing of brain tumors
Dataset
EGAD00001003382
-
WGS data of paediatric BCR::ABL1 acute lymphoblastic leukemia
Dataset
EGAD50000002185
-
WGS data of paediatric B-other B cell acute lymphoblastic leukemia (set5)
Dataset
EGAD50000002160
-
Machine learning to detect the SINEs of cancer
Study
EGAS00001007169
-
Meningioma Exome
Dataset
EGAD00001000099
-
RNA-seq of tumor samples from clear cell renal cell carcinoma patients included in the Translational Program of the NIVOREN GETUG-AFU-26 trial
Study
EGAS50000001057
-
WGS data of paediatric ETV6::RUNX1 B cell acute lymphoblastic leukemia (set3)
Dataset
EGAD50000002287
-
RNA-seq after drug perturbation of primary lymphoma samples
Dataset
EGAD50000002166
-
Bulk RNA-sequencing data of advanced hepatocellular carcinoma (HCC) patients treated with atezolizumab plus bevacizumab.
Dataset
EGAD50000001227